Deutsche Bank’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-824
| Closed | -$22.2K | – | 3932 |
|
|
2023
Q1 | $22.2K | Buy |
824
+221
| +37% | +$5.95K | ﹤0.01% | 3669 |
|
|
2022
Q4 | $21.3K | Buy |
603
+10
| +2% | +$354 | ﹤0.01% | 3724 |
|
|
2022
Q3 | $134K | Sell |
593
-92
| -13% | -$20.8K | ﹤0.01% | 3154 |
|
|
2022
Q2 | $129K | Buy |
685
+106
| +18% | +$20K | ﹤0.01% | 3368 |
|
|
2022
Q1 | $144K | Sell |
579
-69
| -11% | -$17.2K | ﹤0.01% | 3402 |
|
|
2021
Q4 | $101K | Buy |
648
+34
| +6% | +$5.3K | ﹤0.01% | 3637 |
|
|
2021
Q3 | $123K | Sell |
614
-19
| -3% | -$3.81K | ﹤0.01% | 3758 |
|
|
2021
Q2 | $162K | Sell |
633
-74
| -10% | -$18.9K | ﹤0.01% | 3853 |
|
|
2021
Q1 | $187K | Sell |
707
-62
| -8% | -$16.4K | ﹤0.01% | 3630 |
|
|
2020
Q4 | $284K | Buy |
769
+255
| +50% | +$94.2K | ﹤0.01% | 3221 |
|
|
2020
Q3 | $125K | Buy |
514
+127
| +33% | +$30.9K | ﹤0.01% | 3399 |
|
|
2020
Q2 | $111K | Sell |
387
-1,369
| -78% | -$393K | ﹤0.01% | 3343 |
|
|
2020
Q1 | $358K | Buy |
1,756
+1,324
| +306% | +$270K | ﹤0.01% | 2640 |
|
|
2019
Q4 | $192K | Buy |
432
+210
| +95% | +$93.3K | ﹤0.01% | 3200 |
|
|
2019
Q3 | $67K | Sell |
222
-706
| -76% | -$213K | ﹤0.01% | 3681 |
|
|
2019
Q2 | $293K | Sell |
928
-56
| -6% | -$17.7K | ﹤0.01% | 3556 |
|
|
2019
Q1 | $412K | Sell |
984
-473
| -32% | -$198K | ﹤0.01% | 3514 |
|
|
2018
Q4 | $443K | Sell |
1,457
-362
| -20% | -$110K | ﹤0.01% | 3380 |
|
|
2018
Q3 | $655K | Sell |
1,819
-96
| -5% | -$34.6K | ﹤0.01% | 3566 |
|
|
2018
Q2 | $701K | Buy |
+1,915
| New | +$701K | ﹤0.01% | 3604 |
|
|
2018
Q1 | – | Sell |
-388
| Closed | -$162K | – | 5013 |
|
|
2017
Q4 | $162K | Sell |
388
-2,686
| -87% | -$1.12M | ﹤0.01% | 3923 |
|
|
2017
Q3 | $1.01M | Buy |
3,074
+1,407
| +84% | +$464K | ﹤0.01% | 2957 |
|
|
2017
Q2 | $395K | Buy |
1,667
+329
| +25% | +$78K | ﹤0.01% | 3482 |
|
|
2017
Q1 | $458K | Sell |
1,338
-25
| -2% | -$8.56K | ﹤0.01% | 3044 |
|
|
2016
Q4 | $474K | Buy |
1,363
+441
| +48% | +$153K | ﹤0.01% | 3122 |
|
|
2016
Q3 | $369K | Sell |
922
-135
| -13% | -$54K | ﹤0.01% | 3255 |
|
|
2016
Q2 | $627K | Buy |
1,057
+514
| +95% | +$305K | ﹤0.01% | 3103 |
|
|
2016
Q1 | $273K | Sell |
543
-56
| -9% | -$28.2K | ﹤0.01% | 3420 |
|
|
2015
Q4 | $395K | Buy |
599
+585
| +4,179% | +$386K | ﹤0.01% | 3295 |
|
|
2015
Q3 | $6K | Buy |
14
+2
| +17% | +$857 | ﹤0.01% | 4545 |
|
|
2015
Q2 | $6K | Sell |
12
-261
| -96% | -$131K | ﹤0.01% | 4646 |
|
|
2015
Q1 | $2.33M | Buy |
273
+230
| +535% | +$1.96M | ﹤0.01% | 2307 |
|
|
2014
Q4 | $375K | Buy |
43
+23
| +115% | +$201K | ﹤0.01% | 3728 |
|
|
2014
Q3 | $94K | Sell |
20
-1
| -5% | -$4.7K | ﹤0.01% | 4225 |
|
|
2014
Q2 | $148K | Buy |
21
+17
| +425% | +$120K | ﹤0.01% | 4120 |
|
|
2014
Q1 | $18K | Buy |
+4
| New | +$18K | ﹤0.01% | 4783 |
|